GlassScriptPhysician profile
Ryan J Michel
NPI 1275972473
$2,674.84
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $371 · 2022: $659 · 2023: $629 · 2024: $1,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,611 · Entertainment: $33.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,611.23 |
| Entertainment | $33.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $517.59 | 2021-2024 | Acrysof Iq Vivity, Rocklatan, Lensx |
| Abbvie INC. | $360.48 | 2022-2024 | |
| Tarsus Pharmaceuticals, INC. | $308.58 | 2024 | Xdemvy |
| Biotissue Holdings INC. | $230.23 | 2021-2024 | |
| Bausch & Lomb Americas INC. | $230.10 | 2022-2024 | Miebo, Xiidra, Envista Mx60 Iol |
| Carl Zeiss Meditec, INC. | $178.44 | 2021-2022 | |
| Carl Zeiss Meditec USA, INC. | $130.84 | 2024 | Atlas 500, Quatera 700, Mel 90 |
| Glaxosmithkline, LLC. | $120.02 | 2023 | Arexvy |
| Ocular Therapeutix, INC. | $117.79 | 2024 | Dextenza |
| E.R. Squibb & Sons, L.L.C. | $87.73 | 2023-2024 | Opdivo |
| New World Medical,INC. | $51.71 | 2021-2024 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Allergan, INC. | $44.56 | 2021-2022 | |
| Rayner Intraocular Lenses Limited | $39.38 | 2022-2023 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Dompe US, INC. | $38.90 | 2024 | Oxervate |
| Ivantis, INC | $38.49 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $35.78 | 2021 | |
| Optos, INC. | $33.36 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $21.84 | 2022 | |
| Novartis Pharmaceuticals Corporation | $21.33 | 2022 | |
| Thea Pharma INC. | $21.06 | 2023 | Iyuzeh |
| Johnson & Johnson Surgical Vision, INC. | $17.22 | 2022 | |
| Kala Pharmaceuticals, INC. | $15.40 | 2022 | |
| Sight Sciences, INC. | $14.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Michel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.